Results 41 to 50 of about 38,166 (233)
Objective: In response to an outbreak of circulating vaccine-derived poliovirus (cVDPV) type 2 in the Philippines in 2019–2020, several rounds of supplementary immunization activities using the monovalent type 2 oral poliovirus vaccine (OPV) were ...
SweetC B Alipon +12 more
doaj +1 more source
Poliomyelitis amidst the COVID-19 pandemic in Africa: Efforts, challenges and recommendations
Poliomyelitis is the leading infectious cause of acute flaccid paralysis among children under five years of age, caused by the Wild Poliovirus, with no medical cure other than prevention through vaccination.
Olivier Uwishema +7 more
doaj +1 more source
Objective: To describe the prevalence of neutralizing antibodies against poliovirus (PV1, PV2, and PV3) in blood samples of healthcare professionals aged 20 to 50 years.
José Cassio de Moraes +2 more
doaj +2 more sources
Oral and inactivated poliovirus (PV) vaccines have contributed toward the global eradication of wild PV2 and PV3, as well as the elimination of PV1 in most countries.
Angela Maria Vittoria Larocca +5 more
doaj +1 more source
The enhanced inactivated poliovirus vaccine was first introduced in 2002, and several inactivated poliovirus vaccines are licensed in Korea. Reliable data by a prospective study on the immunogenicity and safety of the inactivated poliovirus vaccines in ...
Byung Ok Kwak +8 more
doaj +1 more source
The Pathology of Poliomyelitis and the Vaccines and Nonvaccine Therapy [PDF]
Poliomyelitis is an exclusively human disease that mainly affects children. Clinical features of poliomyelitis can be varied, from mild illness to the most severe paralysis, and the factor why poliomyelitis has different performances in individuals has ...
Chen Yushuo, Yue Tianrui, Zhang Zixiao
doaj +1 more source
Promising opportunities to improve polio vaccines
Polioviruses belong to Enterovirus C species and cause severe lesions of the nervous system. In the post-polio eradication era, the World Health Organisation recommends inactivated polio vaccines for effective long-term protection of the population.
E. E. Evreinova +4 more
doaj +1 more source
Immunogenicity of full and fractional dose of inactivated poliovirus vaccine for use in routine immunisation and outbreak response: an open-label, randomised controlled trial. [PDF]
Snider CJ +10 more
europepmc +2 more sources
We recently reported a lack of interference between inactivated rotavirus vaccine (IRV) and inactivated poliovirus vaccine (IPV) and their potential dose sparing when the two vaccines were administered intramuscularly either in combination or standalone ...
Sung-Sil Moon +11 more
doaj +1 more source
Feasibility of jet injector use during inactivated poliovirus vaccine house-to-house vaccination campaigns. [PDF]
Farag NH +5 more
europepmc +3 more sources

